Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 6Phase 1/2 4Phase NA 1Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 12Ovarian Neoplasms 11Fallopian Tube Neoplasms 10Carcinoma, Non-Small-Cell Lung 7Pancreatic Neoplasms 5Brenner Tumor 5Lung Neoplasms 4Endometrial Neoplasms 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Carcinoma 3Adenocarcinoma of Lung 3Oropharyngeal Neoplasms 2Neurotoxicity Syndromes 2Mouth Neoplasms 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Carcinosarcoma 2Carcinoma, Transitional Cell 2Vomiting 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Recurrent Uterine Corpus Carcinoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Cancer Resectable 1Pancreatic Adenocarcinoma 1Pancreas Adenocarcinoma 1Pain 1Ovarian Germ Cell Cancer 1

Interventions

exemestane 4Tamoxifen 3Paclitaxel 3Letrozole 3Goserelin 3Cyclophosphamide 3pegfilgrastim 2Radiotherapy 2Pyridoxine 2Leuprolide 2Fluorouracil 2Epirubicin 2Capecitabine 2Bevacizumab 2Anastrozole 2trastuzumab biosimilar HLX02 1ribociclib 1elacestrant 1Zoledronic Acid 1Trastuzumab 1Taxes 1Radiosurgery 1Prochlorperazine 1Palonosetron 1PF-05280014 1Ontruzant 1Ogivri 1Neoadjuvant Therapy 1Mometasone Furoate 1Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Breast Neoplasms, Male × Taxes × Clear all
NCT00770809 2025-08-15

Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

National Cancer Institute (NCI)

Phase 3 Completed
305 enrolled 10 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡